Please use this identifier to cite or link to this item: http://hdl.handle.net/11054/1276
Full metadata record
DC FieldValueLanguage
dc.contributorKhialani, B.en_US
dc.contributorAndrianopoulos, Nicken_US
dc.contributorYip, T.en_US
dc.contributorAjani, A.en_US
dc.contributorYudi, M.en_US
dc.contributorFreeman, M.en_US
dc.contributorJaworski, C.en_US
dc.contributorOqueli, Ernestoen_US
dc.contributorBrennan, A.en_US
dc.contributorDuffy, S.en_US
dc.contributorHutchison, S.en_US
dc.contributorHiew, C.en_US
dc.contributorSebastian, M.en_US
dc.contributorStub, Dion.en_US
dc.date.accessioned2019-02-21T02:27:07Z-
dc.date.available2019-02-21T02:27:07Z-
dc.date.issued2018-
dc.identifier.govdoc01253en_US
dc.identifier.urihttp://hdl.handle.net/11054/1276-
dc.description.abstractBackground: This study sought to examine the rate of adoption of the transradial approach (TRA) amongst acute coronary syndrome (ACS) and non-ACS patients undergoing percutaneous coronary intervention (PCI), and to evaluate whether it is associated with superior clinical outcomes. Methods: Temporal trends in using TRA between 2005 and 2017 were assessed in 26,896 patients who underwent PCI with ACS (n = 18,025) and without ACS (n = 8,871) from the Melbourne Interventional Group registry. Clinical and procedural variables, and clinical outcomes were compared between the TRA and femoral access (FA). The primary outcomes were in-hospital bleeding and 30-day major adverse cardiac and cerebrovascular events (MACCE: death, myocardial infarction, target vessel revascularisation, and stroke). Results: Use of the TRA significantly increased from 3.3% (ACS) and 1.4% (non-ACS) in 2005 to 67.0% and 65.0%, respectively, by 2017 (p-for trend <0.01). The TRA was more likely to be used in ACS patients for urgent or rescue PCI, and in those who had received thrombolysis (p < 0.01). There were significantly lower in-hospital bleeding rates using TRA compared to FA in both ACS (1.0% vs 2.4%, p < 0.01)) and non-ACS (0.3% vs 1.1%, p < 0.01) cohorts. Multivariable analyses showed that vascular access (FA vs TRA) was not an independent predictor of 30-day MACCE in ACS (OR 1.01, 95% CI 0.85–1.21) and non-ACS (OR 0.95, 95% CI 0.69–1.32). Conclusions: During a 13-year period there was a marked increase in transradial PCI in Victoria for both ACS and non-ACS patients. Transradial PCI was associated with significantly lower bleeding rates but equivalent MACCE rates.en_US
dc.description.provenanceSubmitted by Gemma Siemensma (gemmas@bhs.org.au) on 2019-02-13T05:22:51Z No. of bitstreams: 0en
dc.description.provenanceApproved for entry into archive by Gemma Siemensma (gemmas@bhs.org.au) on 2019-02-21T02:27:07Z (GMT) No. of bitstreams: 0en
dc.description.provenanceMade available in DSpace on 2019-02-21T02:27:07Z (GMT). No. of bitstreams: 0 Previous issue date: 2018en
dc.titleTrends in vascular access for patients undergoing percutaneous coronary intervention in Australia: a report from the Melbourne Interventional Group Cohort.en_US
dc.typeConferenceen_US
dc.type.specifiedPresentationen_US
dc.bibliographicCitation.conferencedateAugust 2-5then_US
dc.bibliographicCitation.conferencename66th Cardiac Society of Australia and New Zealand Annual Scientific Meeting, the International Society for Heart Research Australasian Section Annual Scientific Meeting and the 12th Annual Australia and New Zealand Endovascular Therapies Meeting.en_US
dc.bibliographicCitation.conferenceplaceBrisbane, Queenslanden_US
dc.subject.healththesaurusTRANSRADIAL APPROACHen_US
dc.subject.healththesaurusPERCUTANEOUS CORONARY INTERVENTIONen_US
dc.subject.healththesaurusACUTE CORONARY SYNDROMEen_US
Appears in Collections:Research Output

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.